Evaluating prodrug characteristics of a novel anticoagulant fusion protein neorudin, a prodrug targeting release of hirudin variant 2-Lys47 at the thrombosis site, by means of in vitro pharmacokinetics

scientific article published on 23 May 2018

Evaluating prodrug characteristics of a novel anticoagulant fusion protein neorudin, a prodrug targeting release of hirudin variant 2-Lys47 at the thrombosis site, by means of in vitro pharmacokinetics is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJPS.2018.05.025
P698PubMed publication ID29802897

P2093author name stringGuifang Dou
Xiaoxia Zhu
Zhiyun Meng
Jide Jin
Ruolan Gu
Xiaona Dong
Hui Gan
Jianglin Liu
P921main subjectthrombosisQ261327
hirudinQ386715
P304page(s)166-177
P577publication date2018-05-23
P1433published inEuropean Journal of Pharmaceutical SciencesQ5412738
P1476titleEvaluating prodrug characteristics of a novel anticoagulant fusion protein neorudin, a prodrug targeting release of hirudin variant 2-Lys47 at the thrombosis site, by means of in vitro pharmacokinetics
P478volume121

Search more.